دورية أكاديمية
An Effective Model for Establishing a Collaborative for the Treatment of COVID-19 in the Rio Grande Valley.
| العنوان: | An Effective Model for Establishing a Collaborative for the Treatment of COVID-19 in the Rio Grande Valley. |
|---|---|
| المؤلفون: | Betancourt-Garcia MM, Arauco-Brown AR, Garcia R, Rosenbaum-Marinaro L, Stutz T, Rao S |
| المصدر: | Journal of health care for the poor and underserved [J Health Care Poor Underserved] 2021; Vol. 32 (3), pp. 1276-1287. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Johns Hopkins University Press Country of Publication: United States NLM ID: 9103800 Publication Model: Print Cited Medium: Internet ISSN: 1548-6869 (Electronic) Linking ISSN: 10492089 NLM ISO Abbreviation: J Health Care Poor Underserved Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2004- : Baltimore, MD : Johns Hopkins University Press Original Publication: Nashville, TN : Institute on Health Care for the Poor and Underserved, Meharry Medical College, c1990- |
| مواضيع طبية MeSH: | Immunization, Passive*, COVID-19/*therapy, COVID-19/blood ; COVID-19/epidemiology ; Communicable Disease Control ; Drug Approval ; Hispanic or Latino ; Humans ; Medically Underserved Area ; Texas/epidemiology ; Tissue Donors ; COVID-19 Serotherapy |
| مستخلص: | The DHR Health Institute for Research and Development spearheaded a region-wide initiative to establish a Rio Grande Valley (RGV) Collaborative for early diagnosis, prevention, and treatment of COVID-19. The Collaborative was established on March 23, 2020, to conserve resources and provide the best clinical care in the face of an imminent regional health crisis in an underserved community, predominantly of Hispanic heritage with some of the highest rates of chronic diseases in the United States. The use of plasma obtained from convalesced SARS-CoV-2-infected donors was approved by the FDA and the RGV Collaborative took this as its initial challenge. To date, over 2,200 patients with severe and life-threatening COVID-19 have successfully received transfusion of convalescent plasma in various health care facilities in the RGV. The RGV Collaborative is a unique model for creating an effective public health strategy for the delivery of quality clinical care, especially in underserved communities. |
| تواريخ الأحداث: | Date Created: 20210823 Date Completed: 20210827 Latest Revision: 20221207 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1353/hpu.2021.0131 |
| PMID: | 34421030 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1548-6869 |
|---|---|
| DOI: | 10.1353/hpu.2021.0131 |